- Home
- VKTX vs LGND Comparison
VKTX vs LGND Comparison
Compare VKTX & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- LGND
- Stock Information
- Founded
- VKTX 2012
- LGND 1987
- Country
- VKTX United States
- LGND United States
- Employees
- VKTX N/A
- LGND 68
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- VKTX Health Care
- LGND Health Care
- Exchange
- VKTX Nasdaq
- LGND Nasdaq
- Market Cap
- VKTX 3.8B
- LGND 3.2B
- IPO Year
- VKTX 2015
- LGND 1992
- Fundamental
- Price
- VKTX $35.22
- LGND $184.52
- Analyst Decision
- VKTX Strong Buy
- LGND Strong Buy
- Analyst Count
- VKTX 14
- LGND 8
- Target Price
- VKTX $87.00
- LGND $144.71
- AVG Volume (30 Days)
- VKTX 4.8M
- LGND 139.7K
- Earning Date
- VKTX 10-22-2025
- LGND 08-05-2025
- Dividend Yield
- VKTX N/A
- LGND N/A
- EPS Growth
- VKTX N/A
- LGND N/A
- EPS
- VKTX N/A
- LGND N/A
- Revenue
- VKTX N/A
- LGND $181,488,000.00
- Revenue This Year
- VKTX N/A
- LGND $18.41
- Revenue Next Year
- VKTX N/A
- LGND $18.87
- P/E Ratio
- VKTX N/A
- LGND N/A
- Revenue Growth
- VKTX N/A
- LGND 53.40
- 52 Week Low
- VKTX $18.92
- LGND $81.74
- 52 Week High
- VKTX $79.10
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- VKTX 60.22
- LGND 58.17
- Support Level
- VKTX $33.00
- LGND $179.00
- Resistance Level
- VKTX $36.11
- LGND $194.44
- Average True Range (ATR)
- VKTX 2.02
- LGND 5.69
- MACD
- VKTX 0.09
- LGND -0.55
- Stochastic Oscillator
- VKTX 73.40
- LGND 41.95
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.